Maria del Pilar Aguinaga to Anemia, Sickle Cell
This is a "connection" page, showing publications Maria del Pilar Aguinaga has written about Anemia, Sickle Cell.
Connection Strength
0.428
-
Farrell K, Dent L, Nguyen ML, Buchowski M, Bhatt A, Aguinaga Mdel P. The relationship of oxygen transport and cardiac index for the prevention of sickle cell crises. J Natl Med Assoc. 2010 Nov; 102(11):1000-7.
Score: 0.318
-
Jones KM, Niaz MS, Brooks CM, Roberson SI, Aguinaga MP, Hills ER, Rice VM, Bourne P, Bruce D, Archibong AE. Adverse effects of a clinically relevant dose of hydroxyurea used for the treatment of sickle cell disease on male fertility endpoints. Int J Environ Res Public Health. 2009 03; 6(3):1124-44.
Score: 0.071
-
Popp RA, Popp DM, Shinpock SG, Yang MY, Mural JG, Aguinaga MP, Kopsombut P, Roa PD, Turner EA, Rubin EM. A transgenic mouse model of hemoglobin S Antilles disease. Blood. 1997 Jun 01; 89(11):4204-12.
Score: 0.031
-
Roa D, Kopsombut P, Aguinaga MP, Turner EA. Hydroxyurea-induced denaturation of normal and sickle cell hemoglobins in vitro. J Clin Lab Anal. 1997; 11(4):208-13.
Score: 0.008